Biocon Q1 - Results - F.Y. 25-26

Biocon Q1 - Results - F.Y. 25-26 -

1) Biotechnology firm Biocon Ltd on Thursday (August 7) reported a steep 95.2% year-on-year (YoY) decline in consolidated net profit at ₹31.4 crore for the quarter ended June 30, 2025, compared to ₹659.7 crore in the corresponding period last year. - 2) Revenue from operations, however, grew 1 4.8% YoY to ₹3,942 crore, against ₹3,433 crore in the year-ago period. This figure too fell short of the CNBC-TV18 poll, which had pegged revenue at ₹4,096.2 crore. 3) On the operational front, EBITDA rose 20.7% YoY to ₹749 crore, up from ₹620.4 crore in Q1FY25. The operating margin stood at 19%, a modest improvement over 18.1% last year but below the CNBC-TV18 estimate of 20.8%. 4) On the operational front, EBITDA rose 20.7% YoY to ₹749 crore, up from ₹620.4 crore in Q1FY25. The operating margin stood at 19%, a modest improvement over 18.1% last year but below the CNBC-TV18 estimate of 20.8%. 5) Overall results are below expectations. 6) All this is for information. 7) This is not a buy/sell recommendation. Thank you, Technofunda24